Oxfordshire hospitals' most requested language interpreter revealed

The most requested language interpretation service at Oxfordshire's hospitals is not French, Spanish, Mandarin Chinese nor Arabic.
Instead, a recent freedom of information request to the Oxfordshire NHS Foundation Trust has revealed that it is Portuguese.
The trust provides physical, mental health and social care for people of all ages across Oxfordshire, Buckinghamshire, Swindon, Wiltshire, Bath and Somerset.
Its responsibilities include Abingdon, Bicester, Wallingford, Wantage and Witney community hospitals, as well as numerous other services such as disability and dental care.
READ MORE:
That Portuguese is the most sought-after translation service tallies with data from the latest Census (2021) which reported that it was second – after English – as the most spoken primary language by residents of Oxford, narrowly beating Spanish and Polish.
As well as revealing the most requested language interpretation service for the trust, the freedom of information request showed how much is being spent on interpretation as a whole.
Witney Community Hospital falls under the Oxfordshire NHS Foundation Trust
For the latest year-long period (2024-25) this was £185,659, significantly down from the same time a year before (2023-24) when it was £211,003.
It is also reduced from the timeframe before that (2022-23) when £204,475 was spent on translation across the trust.
Missed a copy of the Oxford Mail you wanted? Here's what to do https://t.co/n1aacoWEDF
— Oxford Mail (@TheOxfordMail) May 13, 2024
This comes after the Daily Mail revealed that the NHS has spent almost £80 million on language and interpretation services since 2020 for patients – not just for non-English speakers but also the hard of hearing and blind people.
Responding to the paper, an NHS spokesperson said: 'Translation and interpretation services are a legal requirement and essential to deliver effective and safe patient care.
'It is right the NHS offers these services for those who need them, including translations, sign language and documents.'
Even so, the money spent on translation services nationally has led to criticism from some MPs and groups such as the Taxpayers' Alliance.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

9 hours ago

• Yahoo

Waste depot staff given free health checks as part of initiative in Colchester

STAFF at a waste and recycling depot in Colchester have received free health checks as part of a workplace wellbeing initiative. The checks were conducted at the Shrub End depot by the NHS on the Open Road SOS Bus using a SiSU machine. This initiative identified staff with possible undiagnosed hypertension and formed part of Colchester Council's week-long focus on the health and wellbeing of its staff. The SiSU machine measured not only blood pressure, but also heart rate, body composition, and body mass index. Enthusiastic depot employees hopped aboard the bus for their checks. Mike Watkins, one of the staff members, expressed his gratitude, saying: "It makes us feel valued. "I'm keen to find out about my blood pressure and learn what to do about it if it's not where it should be." Martyn Peck (Image: Suffolk and North East Essex ICB) Worker Darren Hammett added: "I haven't had my blood pressure checked in a while, so I've come along today to find out what it is." The initiative also received positive feedback from staff, including Kevin Cook, who recommended other large workplaces to adopt similar practices. He said: "It's important to look after your health." Similarly, Martyn Peck expressed his desire for reassurance about his health and praised the initiative for aiding the early detection of health problems. Dr. Hasan Chowhan, senior partner at Creffield Medical Group, outlined the significance of the initiative. He said: "High blood pressure is a silent killer. "Many people don't realise they have the condition until they have a heart attack or stroke. "The good news is that it's possible to get it under control. For some that may mean making a few lifestyle changes; others will need to take medications as well. "These simple steps could save your life. "They could also help save your quality of life as both strokes and heart attacks can leave people with long-term disabilities." The initiative was planned with the indispensable support of the NHS Suffolk and North East Essex Integrated Care Board. Nerinda Evans, director of strategic programmes at the care board, said: "We helped to put on this event because we saw it as a great opportunity to talk to people directly about the dangers of undiagnosed high blood pressure. "Prevention is the key thing here. We are actively trying to support people before they have a heart attack or stroke. "We hope everyone at Colchester Recycling Centre will tell their friends and family about the importance of checking your blood pressure to help spread this important message.' The Open Road SOS Bus, commissioned by Essex County Council, plays a vital role in delivering workplace health checks, acting as a key aspect of its services. Stacey Banner, welfare and volunteer manager for the bus, said: "Early detection is crucial in preventing serious health conditions. "We are dedicated to ensuring that all individuals have access to fundamental healthcare services." This event also provided information about the new urgent care dental service, offering NHS treatment in one to seven days for problems like toothache, infections, and broken fillings. John Spence, councillor responsible for children's services, adult social care, public health and integration at Essex County Council, said: "Healthy workforces are happy and competitive workforces. "By taking the stations directly to local people, we are making health checks accessible and helping residents, especially those in manual jobs, take control of their health." The council's proactive approach extends beyond health checks, offering mental health support and other wellbeing aids for staff. Julie Young, deputy leader of Colchester Council and councillor responsible for housing, said: "We're proud to support initiatives that put our staff's wellbeing first. "The health checks at the household waste and recycling depot are a simple but powerful reminder that prevention saves lives. "This is exactly the kind of proactive approach we want to see more of across our workplaces – making it easier for people to take control of their health and stay well." People wanting workplace health checks, mental health support, or other staff wellbeing support can contact:

Newsweek

12 hours ago

• Newsweek

Exclusive: We Thought Having a Baby Was 'Impossible.' Then Doctors Used AI

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The parents of the world's first baby born thanks to AI exclusively told Newsweek how a new IVF procedure powered entirely by artificial intelligence made the "impossible" a reality. The couple's hopes of starting a family were crushed when Edna, 42, and Tony, 45, were diagnosed with infertility issues, including Edna's ovarian insufficiency. But in 2023, they were introduced to a prototype study led by Conceivable Life Sciences through Hope IVF—a private clinic in Mexico City. From left to right: Luis, Dr Luis Miguel Campos (the patients' clinician), parents Edna and Tony. From left to right: Luis, Dr Luis Miguel Campos (the patients' clinician), parents Edna and Tony. Conceivable The precision of AI This study proved it was possible to control robotics within the IVF lab to perform ICSI, otherwise known as Intracytoplasmic Sperm Injection, remotely to create an embryo. This means embryos created through the robotic ICSI step receive consistent treatment with high precision and a more controlled approach to combining the egg and sperm, compared to current manual methods. The surgeon still oversees the robot and the processes, but with much improved outcomes. Edna and Tony—who are using their middle names for privacy—spoke exclusively to Newsweek about how they became the first family shaped by AI. "We represent expectations and hope for all those couples who are unable to reach their goal to become parents," they said through Spanish translation. "Once we heard the baby's heartbeat, we felt like we reached something that seemed previously impossible." A scalable model for fertility treatment The prototype study involved 41 patients and to date, has resulted in 21 pregnancies and 18 live births. Its system sees AI-powered robots help human doctors in a first step towards automating IVF treatments. The remote ICSI procedure used allows for a much gentler approach to embryo creation, helping improve quality outcomes at a microscopic level. Baby Luis (his real name) was born in Morelia in November 2024. Now seven-months-old, he has become the first baby to be conceived thanks to AI. Inside the AI system Chief medical officer at Conceivable Life Sciences, Dr. Alejandro Chavez-Badiola and one of the principal investigators on the paper, shared two scenarios: "Am I the lucky patient who is going to be treated by the best embryologist in the world at 8 a.m. after a cup of coffee and with a smile on their face, fully focused," he told Newsweek. "Or am I going to be the unlucky patient who is going to be treated by the best embryologist in the world at 1 p.m. when they're about to inject their 17th egg, thinking about lunch and having just received a distressing phone call from their partner." With this new system, the entire procedure uses mathematical algorithms and robotics to carry out the fertilization process step-by-step, with future precision likely to be beyond human capability. "Automation is not only allowing us to standardize these issues with the precision of robots, but to scale this [and] to make sure that every patient anywhere in the world, at any given time, can be treated by the best embryologists," Dr. Chavez-Badiola said. Remote ICSI photography. Remote ICSI photography. Conceivable Tony told Newsweek that the couple didn't have concerns about using the technology to finally become parents. "Although it can be directed to other purposes like weapons or other negative aspects, I feel like it should be applied on a daily basis, because well done, its purpose will be at the service of mankind," he said. While there will always be a clinical team overseeing the automated lab, remote control enables global teams to manage automated labs beyond regular hours, allowing for 18–20-hour workdays. Additionally, as the system can be operated remotely, a specialist in one country can carry out fertilization procedures for patients in another. Cost and duration were also differing factors from traditional methods, but the couple put their trust in the team at Conceivable. "By being more optimal and efficient, I feel like it will reduce the amount of attempts and the necessity of medications," Edna told Newsweek. Edna said that the process was fraught with emotion, given the negative outcomes of their previous IVF rounds. Edna was working in another city when she took the pregnancy test. "When I told Tony the news I was pregnant, it was a delightful surprise for him," she told Newsweek. "We were very happy." Luis, the first baby born from remote ICSI. Luis, the first baby born from remote ICSI. Conceivable The success rate of 51 percent aligns with industry standards, according to the Vienna Consensus. However, in their trials, the researchers also found that embryos created using this AI system had an as good—if not better—development potential than those made by humans alone, resulting in high-quality blastocysts—the stage at which embryos are typically relocated from an embryo transfer catheter to the uterus. Edna and Tony's clinician Dr. Luis Miguel Campos told Newsweek that once he had explained the process of ICSI to them, they saw it as an opportunity. "I joined this program to help two beautiful humans achieve their when they heard they were pregnant, I cried like never before," he said. As for next steps at Conceivable, Dr. Campos said consistency in outcomes is a top priority, eventually leading to an improvement in access for any patient around the world. "By [producing] consistency in results, the control process will imply reducing costs and be more efficient," he said. Ethics and AI Dr. Alexander Kotlyar, a reproductive endocrinologist and infertility specialist at Genesis Fertility, told Newsweek emerging AI tools in fertility can enhance core ethical principles, provided they are carefully assessed and properly trained. "The ethical debate around AI reminds me of the long-standing tug-of-war behind genetic testing of embryos," he said. "In both cases, there is concern about how the use of new technology, like DNA testing techniques, can truly benefit patient outcomes, [for example], getting pregnant and having a live birth." Dr. Kotlyar explained the use of AI in the fertility field has grown significantly since the first "test tube" baby was born over forty years ago. This development can be partly attributed to the fact that the processes behind AI algorithms are often not transparent, which raises questions about their outcomes and reliability. "This concern is even more profound with AI since decision-making is, at least partly, given to a machine," he told Newsweek. "However, I would reassure patients and the public that in both cases, the technology is always tested against the principles of core medical ethics and if we cannot stay true to those principles, then we do not use the technology." Hope for future parents For Edna and Tony, being the first successful participants of the prototype clinical trial is a dream come true. "We were fortunate to be selected over other candidates for this first treatment, and we feel blessed," they told Newsweek. "We encourage all those couples who are on the journey to becoming parents to not abandon their dreams and hopes." The couple received strong support from both sides of their families. "Some of them felt a little concerned but in the end, everyone was really happy for our outcome," Tony said. When he's old enough, both Edna and Tony will happily tell Luis that he was conceived using AI. "There's a lot of ignorance and certain concerns about technology, but we will explain gladly to our son." ‌Do you have a tip on a health story that Newsweek should be covering? Do you have a question about IVF? Let us know via health@ Reference Mendizabal-Ruiz, G., Chavez-Badiola, A., Hernández-Morales, E., Valencia-Murillo, R., Ocegueda-Hernández, V., Costa-Borges, N., Mestres, E., Acacio, M., Matia-Algué, Q., Farías, A. F.-S., Carreon, D. S. M., Barragan, C., Silvestri, G., Martinez-Alvarado, A., Olmedo, L. M. C., Aguilar, A. V., Sánchez-González, D. J., Murray, A., Alikani, M., & Cohen, J. (2025). A digitally controlled, remotely operated ICSI system: Case report of the first live birth. Reproductive BioMedicine Online, 50(5).

Yahoo

20 hours ago

• Yahoo

Weight loss pill set to rival injections after promising studies

A new daily weight loss pill has shown promising results in initial studies. Researchers say amycretin, which can be offered by injection or tablet, helped patients lose a significant amount of weight in the first trials. Those who received higher doses of amycretin as a weekly jab lost 24.3 per cent of their body weight after 36 weeks of treatment, while patients who took daily tablets lost an average of 13.1 per cent of their body weight after 12 weeks. While weight loss jabs have been hailed as transformative by NHS leaders, injections come with additional work for over-stretched health services, so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3 per cent after 36 weeks of treatment. It also showed signs of improving blood sugar levels. Side effects included nausea and vomiting, and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1 per cent of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7 per cent, with a third of participants losing 25 per cent or more of their body weight after 72 weeks.